CRVS
Corvus Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website corvuspharma.com
- Employees(FY) 29
- ISIN US2210151005
Performance
+12.81%
1W
+55.78%
1M
-0.0%
3M
+65.94%
6M
+30.11%
YTD
-29.32%
1Y
Profile
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
Technical Analysis of CRVS 2024-05-10
Overview:
In analyzing the technical indicators for CRVS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-05-12 03:26
13 Penny Stocks with Insider Buying in 2024(Insidermonkey)
- 2024-05-07 05:12
- 2024-05-06 23:07
- 2024-05-06 18:35
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2024-05-06 15:09
- 2024-05-06 08:58
CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024(Investorplace)
- 2024-05-06 04:21
Corvus: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-06 04:01
- 2024-05-02 04:02
- 2024-05-01 20:30
- 2024-04-16 21:35
- 2024-04-09 04:01
- 2024-03-31 21:35
- 2024-03-22 00:00
- 2024-03-20 21:48
- 2024-03-19 18:32
Q4 2023 Corvus Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2024-03-19 04:08
Corvus: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-19 04:02
- 2024-03-13 04:02
- 2024-02-11 20:22
Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up(Yahoo Finance)
- 2024-02-11 19:30
- 2024-02-08 03:05
- 2024-02-06 03:05
- 2024-01-23 04:00
- 2023-12-10 23:00
What Makes Corvus (CRVS) a New Buy Stock(Yahoo Finance)
- 2023-12-08 23:00
- 2023-12-06 20:40
- 2023-11-20 20:40
- 2023-11-07 22:56
- 2023-11-07 19:43
Q3 2023 Corvus Pharmaceuticals Inc Earnings Call(Yahoo Finance)
Page 1 of 4
previousnext